Sildenafil is already approved by the FDA to treat erectile dysfunction and pulmonary hypertension. According to a recent MedicalXpress article, the drug is now a candidate to treat and prevent Alzheimer’s disease as well. A new study, published in Nature Aging, used an algorithm to determine if any FDA-approved drugs could be potential therapies for Alzheimer’s disease. After sifting through a database of over 7 million patients, the team found that sildenafil was associated with 69% fewer incidences of the neurodegenerative disease.
ED Drug Could Have Alzheimer’s Application
The FDA-approved therapy is associated with a 69% reduction in Alzheimer’s disease incidence.
Dec 10, 2021
Recommended
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
